Drug profile · INN
tapinarof
VTAMA
tapinarof (VTAMA) is a aryl hydrocarbon receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Drug details — tapinarof
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
tapinarof (VTAMA) is a aryl hydrocarbon receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Aryl hydrocarbon receptor agonist
Primary target: Aryl hydrocarbon receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is tapinarof?
tapinarof (VTAMA) is a aryl hydrocarbon receptor agonist. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for tapinarof?
VTAMA is a marketed brand name for tapinarof. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tapinarof?
tapinarof has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.